Kiniksa Pharmaceuticals Ltd (NASDAQ:KNSA)

11.05
Delayed Data
As of 4:00pm ET
 +0.94 / +9.30%
Today’s Change
7.36
Today|||52-Week Range
16.68
-6.12%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2016

2017

2018

--
Revenue and IncomeNet Revenues0.000.000.00----
Depreciation And Amortization22.0K28.0K286.0K--
 
 
 
 
 
Operating ExpensesGross Income-22.0K-28.0K-286.0K--
 
 
 
 
General Expenses24.0M65.4M107.9M--
 
 
 
 
Research And Development17.4M56.4M86.6M--
 
 
 
 
Total Operating Expenses24.0M65.4M108.2M--
 
 
 
 
 
Non-Operating ExpensesOperating Income-24.0M-65.4M-108.2M--
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-23.9M-64.9M-103.4M--
 
 
 
 
Income Taxes-36.0K-2.0K-214.0K--
 
 
 
 
Net Income-24.0M-64.9M-103.2M--
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS49.7M49.7M29.5M--
 
 
 
 
Shares To Calculate EPS Diluted49.7M49.7M29.5M--
 
 
 
 
 
Earnings Per ShareEPS-$0.48-$1.31-$3.49--
 
 
 
 
EPS Diluted-$0.48-$1.31-$3.49--